Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.9M Buy
13,926
+37
+0.3% +$13.2K 0.9% 28
2025
Q4
$4.55M Buy
13,889
+67
+0.5% +$21.3K 0.83% 32
2025
Q3
$3.9M Buy
13,822
+9
+0.1% +$2.61K 0.71% 35
2025
Q2
$3.86M Buy
13,813
+529
+4% +$150K 0.75% 34
2025
Q1
$4.14M Buy
13,284
+4
+0% +$1.18K 0.87% 32
2024
Q4
$3.46M Buy
13,280
+2,762
+26% +$819K 0.71% 33
2024
Q3
$3.39M Sell
10,518
-52
-0.5% -$17K 0.75% 33
2024
Q2
$3.3M Buy
10,570
+74
+0.7% +$21.7K 0.75% 31
2024
Q1
$2.98M Buy
10,496
+96
+0.9% +$28.1K 0.67% 34
2023
Q4
$3M Sell
10,400
-176
-2% -$48K 0.74% 30
2023
Q3
$2.84M Buy
10,576
+59
+0.6% +$14.7K 0.76% 31
2023
Q2
$2.33M Buy
10,517
+92
+0.9% +$21.3K 0.61% 40
2023
Q1
$2.52M Buy
10,425
+61
+0.6% +$15K 0.7% 36
2022
Q4
$2.72M Sell
10,364
-273
-3% -$73.2K 0.83% 28
2022
Q3
$2.4M Buy
10,637
+245
+2% +$59.4K 0.83% 29
2022
Q2
$2.53M Buy
10,392
+25
+0.2% +$6.13K 0.9% 27
2022
Q1
$2.51M Buy
10,367
+630
+6% +$145K 0.89% 26
2021
Q4
$2.19M Buy
+9,737
New +$2.06M 0.95% 21

Other funds holding AMGN

Aire Advisors's AMGN Position: Q1 2026 in Review

Aire Advisors increased its Amgen (AMGN) stake by 0.27% in Q1 2026, buying an estimated $13.2K and bringing the position to 13,926 shares worth $4.9M. The position accounts for 0.9% of the portfolio, ranked #28.

Aire Advisors first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Aire Advisors held 13,926 shares of Amgen worth $4.9M as of Q1 2026.
  • Aire Advisors bought 37 Amgen shares in Q1 2026, an estimated $13.2K.
  • Amgen made up 0.9% of Aire Advisors's portfolio in Q1 2026, its #28 holding.
  • Aire Advisors first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Aire Advisors's 13F filing for Q1 2026, filed 6 May 2026.